Dyslipidemia

Dyslipidemia is a medical term used to describe an abnormal amount or distribution of lipids (fats) in the bloodstream. Cholesterol and triglycerides, which are carried in the blood as lipoproteins and are necessary parts of the body's cells, are examples of lipids. Usually, imbalance in these lipids' levels, particularly cholesterol, are referred to as dyslipidemia.

There are various kinds of lipoproteins, such as:

  • Low-density lipoprotein (LDL): High levels of LDL, or "bad" cholesterol, are linked to a higher risk of atherosclerosis and cardiovascular disease. From the liver, LDL transports cholesterol to several body tissues.
  • High-density lipoprotein (HDL): High levels of HDL, or "good" cholesterol, are linked to a lower risk of cardiovascular disease. By transporting extra cholesterol back to the liver for processing and excretion, HDL aids in removing it from the bloodstream.
  • Triglycerides: These are another kind of lipid, and high triglyceride levels are frequently linked to a higher risk of cardiovascular disease.

The lipid abnormalities that can be a part of dyslipidemia include:

  • High levels of LDL cholesterol.
  • Low levels of HDL cholesterol.
  • High levels of triglycerides.
  • An imbalance in the ratio of different lipid components.

Subtopics

LDL Cholesterol | HDL Cholesterol | NON-HDL Cholesterol | High Sensitivity C-Reactive Protein for Risk Assessment | Stratification of Dyslipidemia Risk | Advanced Lipoprotein Testing | Drugs for Treatment of Blood Lipoprotein Abnormalities

Market Statistics:

The global dyslipidemia drug market was worth US$ 11.8 billion in 2018 and is expected to grow at a CAGR of 3.5% from 2019 to 2027. 

North America is the leading contributor to the dyslipidemia medications market. According to the Centers for Disease Control and Prevention (CDC), over 95 million adults in the United States (55% of the population) had total cholesterol levels greater than 200 mg/dL as of 2016. Furthermore, total cholesterol levels higher than 240 mg/dL affect an estimated 29 million adults in the United States.

Tracks

Dyslipidemia

Share this page on your timeline

Submit Abstract
Register Now

 ALSO READ Cardiologist Clinical Cardiology Heart Diseases Hypertension Electrocardiography Cardio-Oncology Interventional Cardiology Nuclear Cardiology Cardiac Nursing Pediatric Cardiology Stroke Cardiac Surgery Thrombosis Heart Arrhythmia Valvular Heart Disease Pulmonology and Cardiology Atherosclerosis Sports Cardiology Cardiac Imaging Vascular Biology Cardiology Case Reports Geriatric Cardiology Cardiovascular Pharmacology Robotic Cardiac Surgery Cardiac Regeneration Dyslipidemia Cardiovascular disease Congestive Heart Failure Acute Coronary Syndrome Advances in Non-Invasive Cardiac Imaging Techniques Innovations in Cardiovascular Surgery Telemedicine and Remote Monitoring in Cardiac Care Cardiac Biomarkers and Diagnostic Tools Cardiogenomics and Personalized Treatment Cardiovascular Epidemiology and Public Health Cardiac Imaging in the Era of 3D and 4D Stem Cell Therapy for Cardiac Regeneration Cardiac Devices and Implantable Technologies Cardiovascular Risk Assessment and Prevention Big Data and Analytics in Cardiology Genetics of Cardiac Arrhythmias Cardiovascular Disease in Women Artificial Heart Devices and Transplants Cardiac Biomaterials and Tissue Engineering Cardiac Imaging for Risk Prediction Integrative Medicine in Cardiology Cardiology Education and Training Innovations Precision Medicine in Cardiology Artificial Intelligence in Cardiovascular Medicine

Tags
Clinical Cardiology Conferences Heart Conferences Heart Diseases Conferences Cardiology Conferences 2024 Asia Heart Congress Japan Pediatric Cardiology Conferences Vascular Biology Conferences Cardiac Surgery Conferences Arrhythmia Conferences Cardiology Conferences 2024 Europe Cardiology Conferences 2024 Australia Cardiology Conferences USA Hypertension Conferences Cardiology Conferences 2024 Cardiologist Conferences

+1 (506) 909-0537